Who is eligible to prescribe Sildigra Super Power 160 Mg ?

Sildigra Super Power 160 mg is a medication that contains two active ingredients: sildenafil citrate (100 mg) and dapoxetine (60 mg). Sildenafil citrate is a phosphodiesterase type 5 (PDE5) inhibitor used to treat erectile dysfunction, while dapoxetine is a selective serotonin reuptake inhibitor (SSRI) used to treat premature ejaculation.

The eligibility to prescribe Sildigra Super Power 160 mg typically falls within the scope of licensed healthcare professionals who are authorized to prescribe medications for erectile dysfunction and premature ejaculation. These may include:

Physicians: Medical doctors, including urologists, primary care physicians, and other specialists, are authorized to prescribe Sildigra Super Power 160 if they determine it to be appropriate based on the patient’s medical history and condition.

Psychiatrists: Psychiatrists, who specialize in mental health and behavioral disorders, may also be eligible to prescribe medications like Sildigra Super Power 160 mg for the treatment of premature ejaculation, particularly if it is related to psychological factors.

Nurse Practitioners and Physician Assistants: In some jurisdictions, nurse practitioners and physician assistants may have prescriptive authority and be authorized to prescribe medications like Sildigra Super Power 160 mg under the supervision of a licensed physician.

It’s important for healthcare professionals to conduct a thorough evaluation of the patient’s medical history, current medications, and overall health status before prescribing Sildigra Super Power 160 mg or any medication containing sildenafil citrate and dapoxetine. Additionally, healthcare providers should provide appropriate counseling regarding the risks, benefits, and potential side effects of the medication.

Patients should only use Sildigra Super Power 160 mg under the guidance and supervision of a licensed healthcare professional and should follow the prescribed dosage instructions carefully. If there are any concerns or questions about the medication, patients should consult with their healthcare provider for guidance and clarification.